A B S T R A C T The chemotactic factor inactivator (CFI) isolated from human serum contains a kininase activity that causes extensive hydrolysis of bradykinin. The highly chemotactic synthetic peptide Met-Leu-Phe was completely hydrolyzed by CFI preparations. The release of the constituent amino acids from this peptide coincided with a loss of its chemotactic activity. The Nformyl, but not the amide derivative, of the leukotactic peptide Met-Leu-Phe was resistant to the action of CFI, as evidenced by chemotactic and biochemical assays. Examination of the specificity of CFI proteolysis revealed that short polypeptide substrates are degraded sequentially from the amino terminus. Larger peptides are less extensively hydrolyzed, and the patterns of hydrolysis are more complex. Inactivation of the bacterial chemotactic factors by CFI was overcome by the addition of high concentrations of peptides which were substrates for CFI. CFI preparations readily hydrolyzed the peptide Arg-Phe-Ala. The constituent amino acids were conveniently identified by thin-layer chromatography method. This procedure afforded a rapid assay for measuring CFI activity in the whole human serum as well as in fractions throughout the purification steps. Moreover, CFI also hydrolyzed L-leucyl-,8-napthylamide at rates comparable to peptides. Thus, L-leucyl-,Pnapthylamide served as a useful substrate for estimating CFI activity in preparations at various stages of purification. This substrate was also useful in kinetic studies. The results from these studies indicate an aminopeptidase activity is the mechanism whereby CFI inhibits the activity of chemotactic substrates.
INTRODUCTION
The chemotactic factor inactivator (CFI ) 1 present in human serum has the ability to irreversibly inactivate a Received for publication 13 November 1975 and in revised form 11 Februiary 1976. 1 Abbreviation used in this paper: CFI, chemotactic factor inactivator.
series of peptides that exhibit leukotactic activity (1, 2) . Although CFI has been thought to be an enzyme, no direct evidence, thus far, has been obtained to support this hypothesis. In this report we provide direct evidence that CFI isolated from human serum has an inherent aminopeptidase activity. METHODS CFI. CFI was isolated from preparations of fresh human serum by a combination of procedures, including salt fractionation, gel filtration using Sephadex G-150 (Pharmacia Fine Chemicals Inc., Piscataway, N. J.), followed by ionic exchange chromatography in DE-52 cellulose, gel filtration in Sephadex G-200, and preparative electrophoresis in Pevikon or polyacrylamide gels. Details of these procedures are given in a recent publication (2) . In several of the experiments to be described, CFI was obtained at the fourth step of fractionation . In other experiments, where specified, further purification involved preparative electrophoresis. Unless otherwise indicated, 50-,ul vol of CFI (15-65 ,&g protein) were incubated with 50 ,l of chemotactic factor and 100 ,IA of sodium phosphate buffer (pH 7.4, 0.05 M).
Chemotactic analysis was performed with rabbit neutrophils suspended in 0.1% bovine serum albumin, using micropore filters with porosity 0.65 ,um and using modified Boyden chambers (3) . Chemotactic counts were determined by the assessment of the total number of migrated cells in five randomly selected microscopic fields, X 140 magnification. Calculation of CFI activity was made after the results of neutrophil migrational responses to 50 Al of the bacterial chemotactic factor. The latter was isolated from the supernatant fluid of an Escherichia coli culture (2) . The amount of inhibition of chemotactic activity was calculated, relative to the chemotactic counts in an untreated chemotactic factor control (1, 2) . Protein was determined by the method of Lowry et al. (4) Elmer Becker (University of Connecticut Health Center, Farmington, Conn.). Bradykinin assays. Bioassay on the estrus rat uterus was performed in the conventional manner (5) . The percent of bradykinin activity lost was calculated after establishing a dose response with a solution of bradykinin at known concentrations. We are indebted to Dr. Richard Freer (Department of Pharmacology, University of Connecticut Health Center) for his assistance.
Amino acid analysis. The amino acid composition of samples was determined using two procedures. The first involved the standard, Moore and Stein method using Beckman Spinco model 120C amino acid analyzer (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) (6) . For all experiments, samples were diluted to 1.0 ml with 0.2 M citrate buffer pH 2.2 to stop the enzymatic reaction. Aliquots were then immediately subjected to quantitative analysis or frozen (-60°C) for later study. The second procedure involved qualitative analysis of amino acids released from peptides after incubation with CFI. This assay was accomplished by thin-layer chromatography using precoated activated silica (Anasil, type C) plates, which were obtained from Analabs, Inc. (North Haven, Conn.). One-dimensional chromatography was performed using a solvent consisting of isopropyl alcohol, formic acid, and water (40: 2: 10). The developed plates were sprayed with ninhydrin solution and the amino acids identified by comparing their mobilities with amino acid standards. Identification of the unknown spots was made on the basis of comparson with standards.
The peptidase activity in CFI preparations was readily assayed by determining the extent of hydrolysis of peptide Arg-Phe-Ala using thin-layer chromatography. 20 Al of peptide (0.1 mM) was incubated with 10 ,IA of CFI preparation, along with 25 Al 50 mM phosphate buffer pH 7.4.
After incubating at 37°C for 1 h, 10-,ul aliquots were spotted on plates for immediate thin-layer chromatagraphy analysis. Peptide bond hydrolysis could be readily detected by the formation of free arginine spots. Spots corresponding to the two other amino acids of this peptide could also be recognized in some CFI digests. The presence of any of the free amino acids was considered a positive evidence for CFI activity.
Leucine aminopeptidase activity. Enzyme activity was assessed spectrophotometrically using the substrate L-leucylp-napthylamide. After hydrolysis, the liberated ,3-napthylamine was reacted with a diazo compound, and the color of the reaction measured according to the procedure described in Analytical and Diagnostic Bulletin no. 251 of Sigma Chemical Co. The reagents for this assay were obtained from the Sigma Chemical Co.
Determination of the pH optimum of the peptidase activity. To assess the pH optimum for leucine aminopeptidase activity in the CFI preparations, Tris-maleate buffer (Sigma Chemical Co.) was used at a concentration of 0.05 M. 50 ,ul of buffer was added to a mixture containing 50
Al CFI and 200 pl substrate, L-leucyl-j8-napthylamide. After incubation for 1 h at 37°C, the assay for free p-napthylamide was performed using the diazonium reagent.
RESULTS
Bradykininase activities in CFI preparations. Highly purified CFI preparations, consisting of a single fglobulin band and only three other a-globulin bands, were obtained by elution from preparative polyacrylamide gels after electrophoresis (2) . As shown in Table   I , incubation of 30 Ag of CFI preparations with 20 lAg bradykinin at pH 7.4 for 4 h at 37°C led to a decrease of bradykinin activity ranging from 12 to 85%. This indicates that the most highly purified preparations of CFI, which appeared as a single band on analytical polyacrylamide gel electrophoresis, contained a bradykininase activity.
To determine the nature of the inactivation of bradykinin by CFI preparations, the a-and i3-globulin forms were incubated with 200 nmol of bradykinin for 1 I Percent loss of chemotactic activity in bacterial factor after incubation for 30 min with CFI. § Each CFI incubation mixture contained 100 nmol of the peptide. formyl-methionine is probably due to its poor reactivity with ninhydrin. These results indicate that Met-LeuPhe, but not its formylated derivative, can be hydrolyzed by CFI.
Hydrolysis of the Hexapeptide by CFI preparations. Highly purified samples (isolated by procedures extending through the preparative electrophoretic step) of CFI were incubated with 100 nmol of the hexapeptide Leu-Trp-Met-Arg-Phe-Ala at different intervals of time (Table IV) . The mixtures were then analyzed for the presence of free amino acids. Both the a-and the fglobulin forms of CFI induced extensive hydrolysis of the peptide. The amino acids present in lowest concentration were phenylalanine and alanine, and these were positioned at the COOH-terminus end of the peptide. When short-time (1 h) incubation of CFI with the hexapeptide was carried out, only the N-terminal amino acid, leucine, was identified. After 2 h a small amount of tryptophan could also be detected. After prolonged incubation all of the constituent amino acids were present in the digest. These results strongly suggest that the action of CFI entails sequential hydrolysis of the peptide from the amino terminus.
Hydrolysis of di-and tripeptides by CFI. Employing the "c" preparation described in Table IV , CFI was incubated for 1 h with four different peptides, listed in Table V . Each mixture was then analyzed for the presence of free amino acids after incubation with CFI. Half of all the component amino acids in the Arg-PheAla preparation were released after incubation with CFI. The amidated peptide Pro-Leu-Gly-NH2 also showed evidence of hydrolysis by CFI, although less extensively than Arg-Phe-Ala substrates. The dipeptide N-formyl-Met-Phe was resistant to hydrolysis, while Met-Phe-NH2 was readily hydrolyzed by CFI. These findings support those presented in Tables III and IV and are consistent with the action of an aminopeptidase.
Analysis of peptide hydrolysis by thin-layer chromatography. To ascertain if differences could be demonstrated between the peptidase activities of the a-and the f-globulin forms of CFI, series of di-through octapeptides were incubated with CFI preparations for 2 or Table III indicated that with synthetic peptides of known structure, the mechanism of CFI action was related to an aminopeptidase activity. To assess if peptides (which lack chemotactic activity but are susceptible to hydrolysis by CFI) would protect the bacterial chemotactic factor from inactivation by CFI, the experiment outlined in Table VII was performed. Four different peptides, each known to be substrates of CFI but none having chemotactic activity (Table VI) , were added at high concentration (1 mM) to a solution containing the bacterial factor followed by the addition of CFI. After incubation at 37°C for 30 min, the samples were diluted to 1.0 ml with Hank's medium, and the amount of residual chemotactic activity determined. Appropriate controls were done in which the bacterial factor and peptides were incubated together in found. The data in Table VII indicate that each of the four peptides tested was able to block the CFI-induced inhibition of the chemotactic factor. The 86% loss of chemotactic activity caused by CFI dropped from 60 to 11 to 0% upon addition of various peptide substrates. These data suggest that the CFI-induced inhibition of the bacterial chemotactic factor is due to the proteolytic property of CFI.
Association of CFI, leucine aminopeptidase, and ArgPhe-Ala protease activities during the purification steps of CFI. CFI was isolated by the multi-step procedures recently described (2) . In each of these steps CFI, leucine aminopeptidase, and hydrolase activity for the peptide Arg-Phe-Ala were examined. As described earlier, CFI activity was measured by the loss of chemotactic activity in this bacterial factor. In addition, leucine aminopeptidase was measured quantitatively by hydrolysis of Leu-P-NA, and hydrolysis of Arg-PheAla using thin-layer chromatography was also employed. The coincidence of each of these three activities during purification of CFI is shown in Figs. 1-3 . These steps include ion-exchange chromatography (Fig. 1) , gel filtration in Sephadex G-200 (Fig. 2) , and preparative electrophoresis (Fig. 3). (The initial purification step involving gel filtration on Sephadex G-150 is not shown, but all three activities also coincided in the same fractions during this gel filtration.) The findings suggest that all three activities reflect the action of the same enzyme.
Effect of pH on the leucine aminopeptidase activity. The pH optimum of a preparation of CFI, which contained both the a-and the P-globulin forms of the inactivator, was examined for leucine aminopeptidase activity over a pH range from 5.0 to 9.0 buffer. Using a (Figs. 3, 4) , bradykinin (Table I) , and each inactivates a series of synthetic peptides (Table  VI) .
To what extent the aminopeptidase activity in CFI is related to the well-known leucine aminopeptidase enzyme could not be deduced. Leucine aminopeptidase has been most extensively studied after isolation from hog 
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I kidney (9) . Much less work has been done with a similar, perhaps identical, enzyme present in human serum (10) . Leucine aminopeptidase isolated from renal tissue has considerably higher pH optimum (9) when compared with the enzyme described in this report (Fig.   5 ). In view of our fractionation data indicating that at every step of the fractionation procedures the aminopeptidase and CFI activities coincide (Figs. 1-3) , it seems likely that the aminopeptidase in human serum is identical with CFI, although the experiments do not establish if the aminopeptidase exhibits preferential reactivity with an amino-terminal leucine. Although CFI preparations clearly showed hydrolytic activity towards the amino-terminal residue of the various synthetic peptides examined, the hydrolysis pattern of bradykinin appeared not to be strictly sequential from the amino terminus. The stoichiometry shown in Table II , however, could be due to the presence of three prolyl residues in the bradykinin molecule. Waley and co-workers (11) report that incomplete hydrolysis of a peptide by aminopeptidases may occur if proline residue is present. They noted that hydrolysis of peptide Ala-Tyr-Glu-Pro-Val-Trp by swine kidney aminopeptidase M gave amino acids Ala, Tyr, Val, and Trp and a diketopiperazine of Glu-Pro (11). The latter peptide derivative was not further hydrolyzed. Thus, CFI digestion of peptides containing proline may yield a complex pattern of hydrolysis.
The elevated levels of leucine aminopeptidase described in the serums of humans with malignant neoplasms is of considerable interest since we have recently demonstrated that serums from patients with Hodgkin's disease have elevated levels of CFI (12) . Recently, we have also found that rats bearing malignant tumors in the peritoneal cavity have high levels of CFI in the accompanying ascitic fluid (13) . If leucine aminopeptidase activity and CFI are identical (the evidence for which is compelling), it seems reasonable to postulate that the previously recognized presence of leucine aminopeptidase activity in tumor-bearing states may be associated with defects in the ability to express inflammatory responses that involve leukotactic mechanisms (13) .
Finally, it should be noted that the aminopeptidase basis for CFI activity is enzymatically very different from that of the anaphylatoxin inactivator which destroys the anaphylatoxin activities of the C3 and C5 fragments by a single cleavage of their COOH-terminal arginine (14) . This carboxypeptidase activity (anaphylatoxin inactivator) appears to be the natural regulator of the anaphylatoxins. If the C3 and C5 anaphylatoxin derivatives actually contain leukotactic activities (for which there is some evidence), then inactivation of their biological activities could occur by the action either of the carboxypeptidase (anaphylatoxin inactivator) or of the aminopeptidase (CFI). Which of these inactivators is biologically more important has yet to be determined.
